Zhejiang Tailin Bioengineering Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.053x

Zhejiang Tailin Bioengineering Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Tailin Bioengineering Co Ltd (300813) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.25 Million ≈ $6.18 Million USD) by net assets (CN¥804.29 Million ≈ $117.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Tailin Bioengineering Co Ltd (2013–2025)

Cash flow conversion efficiency of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025. This chart illustrates how Zhejiang Tailin Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300813 live share price for real-time trading data and today's change.

Zhejiang Tailin Bioengineering Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang Tailin Bioengineering Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Tailin Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Tailin Bioengineering Co Ltd ranked by their cash flow conversion efficiency. Also see 300813 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Beijing Infosec Technologies Co. Ltd. A SHG:688201	N/A
Chengdu Dahongli Machinery Co Ltd SHE:300865	0.015x
Falcon's Beyond Global, Inc. Class A Common Stock NASDAQ:FBYD	0.080x
Lowland Investment Co LSE:LWI	0.011x
Baader Bank Aktiengesellschaft F:BWB	N/A
Jiangsu Newamstar Packaging Machinery Co Ltd SHE:300509	0.185x
Swedencare publ AB ST:SECARE	0.007x
PharmaSGP Holding SE F:PSG	0.115x

Annual Cash Flow Conversion Efficiency for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025. Review Zhejiang Tailin Bioengineering Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥804.29 Million ≈ $117.69 Million	CN¥57.11 Million ≈ $8.36 Million	0.071x	+136.34%
2024-12-31	CN¥820.73 Million ≈ $120.10 Million	CN¥24.66 Million ≈ $3.61 Million	0.030x	+911.17%
2023-12-31	CN¥650.24 Million ≈ $95.15 Million	CN¥1.93 Million ≈ $282.70K	0.003x	-97.85%
2022-12-31	CN¥647.45 Million ≈ $94.74 Million	CN¥89.39 Million ≈ $13.08 Million	0.138x	+90.94%
2021-12-31	CN¥497.38 Million ≈ $72.78 Million	CN¥35.96 Million ≈ $5.26 Million	0.072x	-69.78%
2020-12-31	CN¥444.24 Million ≈ $65.01 Million	CN¥106.28 Million ≈ $15.55 Million	0.239x	+88.75%
2019-12-31	CN¥229.11 Million ≈ $33.53 Million	CN¥29.04 Million ≈ $4.25 Million	0.127x	-33.89%
2018-12-31	CN¥194.70 Million ≈ $28.49 Million	CN¥37.33 Million ≈ $5.46 Million	0.192x	+21.87%
2017-12-31	CN¥146.48 Million ≈ $21.44 Million	CN¥23.04 Million ≈ $3.37 Million	0.157x	-42.03%
2016-12-31	CN¥116.31 Million ≈ $17.02 Million	CN¥31.56 Million ≈ $4.62 Million	0.271x	+7.74%
2015-12-31	CN¥97.42 Million ≈ $14.26 Million	CN¥24.54 Million ≈ $3.59 Million	0.252x	-20.82%
2014-12-31	CN¥55.04 Million ≈ $8.05 Million	CN¥17.51 Million ≈ $2.56 Million	0.318x	+79.38%
2013-12-31	CN¥64.92 Million ≈ $9.50 Million	CN¥11.51 Million ≈ $1.68 Million	0.177x	--

About Zhejiang Tailin Bioengineering Co Ltd

SHE:300813 China Medical Devices

Market Cap

$331.83 Million

CN¥2.27 Billion CNY

Market Cap Rank

#14027 Global

#4170 in China

Share Price

CN¥18.71

Change (1 day)

-2.96%

52-Week Range

CN¥17.08 - CN¥30.88

All Time High

CN¥64.43